EDAP TMS S.A. Partnership Wins EUR 2.4 Million Grant for Development of Innovative Imaging Solution for Focal Treatment of Prostate Cancer

Published: Aug 24, 2011

LYON, France, Aug. 24, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that its development partnership has been awarded a EUR 2.4 million grant for further development of Ablatherm-HIFU technology to incorporate improved imaging and diagnostic techniques in line with the focal therapy approach for treating localized prostate cancer. The development partnership, comprised of EDAP, Edouard Herriot Hospital, and SuperSonic Imagine, received the highly competitive grant from Fonds Unique Interministerial (FUI), a French government fund for advancing technical innovation with short and midterm market applications, together with Regional Councils Grand Lyon, PACA, Competitive Clusters Lyonbiopole and Eurobiomed.

Back to news